An additional strength of this study is the inclusion of three different measures of NAFLD, USS and two different liver enzymes ALT and AST, providing stronger evidence for associations between NAFLD and related metabolic traits. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.